Approval · Notice of Compliance 28690 · 2022
PLERIXAFOR INJECTION: Notice of Compliance 28690
Issued August 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28690
- Date
- August 2, 2022
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- MOZOBIL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLERIXAFOR INJECTION | 02490846 | Approved |
Medicinal ingredients
- PLERIXAFOR 20 MG per ML